China National Accor Dividend yield

China National Accor is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. China National Accor is a company from China, and his stocks are publicly traded.

China National Accor stock dividend

China National Accor paid a total dividend of 47 million HKD last year, for a market value of 976 millions (Market Cap 981 millions). China National Accor dividend per share is 0.66 HKD, and his stock market price 13.75 HKD.

According to the chart below, where dividend yield is displayed, China National Accor has a dividend yield of 4.81%, which is higher than the amount offered by both the market average and companies from China. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare China National Accor stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best China dividend stocks list.

China National Accor Dividend Payout

About the ability of China National Accor to maintain his current dividend of HKD 0.66 per share, an amount that accounts for 4.81%, we should study its payout ratio both on earnings and on cash-flows (see chart below). China National Accor payout on ernings is currently 22.07%, which is lower than the market average and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures lead us to believe that there is confidence that China National Accorcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of China National Accor is HKD 4.91 per share, which is higher than the dividend per share paid by the company of HKD 0.66, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of China National Accor, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

China National Accor Dividend History

Below you will find a table with the historical evolution of China National Accor's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	4.81%	0.66	22.07%	71
2022	3.97%	0.73	19.95%	55
2021	4.84%	0.98	23.79%	55
2020	3.17%	0.71	19.61%	55
2019	1.63%	0.45	13.89%	55
2018	1.31%	0.34	11.85%	55
2017	0.97%	0.37	10.91%	55
2016	0.75%	0.36	14.29%	55
2015	0.64%	0.25	10.73%	55

*In millions

Then you can see the evolution of China National Accor dividend stock, and compare it with the average of China stocks and that of the Pharmaceuticals and Biotechnology stocks.

China National Accor Stock performance

Finally, last moth China National Accor showed a return of -4.40% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 5.10% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.